top of page
A L T I T U D E
Life Science Ventures
HOME
ABOUT
PORTFOLIO
Fund IV
Fund III
Fund II
Historical
TEAM
NEWS
CONTACT
More
Use tab to navigate through the menu items.
Companies in the News
Feb 6, 2024
Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
Initial studies will focus on infants and young children; company plans to begin clinical trials in the United States and Australia in...
bottom of page
